Birdwatch Note Rating
2023-08-27 01:40:56 UTC - NOT_HELPFUL
Rated by Participant: F2A70B9BD1FD480ED312EA1C2EA5773C3F423529C9C6BF1C0C3DCB7148C10E20
Participant Details
Original Note:
EBC-46 has shown efficacy to reduce cancer in animal studies only. Clinical trials have since commenced for skin, head and neck, and soft tissue cancers in humans. In 2020 the FDA approved an EBC-46–based medication Stelfonta, to treat mast cell cancer in dogs. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/
All Note Details